Covered recipient · General Payments record
ALFREDO A PAREDES
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$3,599.10
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $709.26 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $424.26 | 24 |
| REVANCE THERAPEUTICS, INC. | $89.34 | 1 |
| Galderma Laboratories, L.P. | $54.36 | 3 |
| Kerecis Limited | $53.22 | 2 |
| Mentor Worldwide LLC | $25.71 | 1 |
| MIMEDX Group, Inc. | $25.06 | 1 |
| Integra LifeSciences Corporation | $22.80 | 1 |
| Smith & Nephew, Inc. | $14.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.65 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179820 | CMS |
| ABBVIE INC. | $21.77 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179822 | CMS |
| ABBVIE INC. | $17.25 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179824 | CMS |
| ABBVIE INC. | $15.96 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179826 | CMS |
| ABBVIE INC. | $9.38 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179828 | CMS |
| ABBVIE INC. | $8.16 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179830 | CMS |
| ABBVIE INC. | $12.24 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179832 | CMS |
| ABBVIE INC. | $28.75 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179834 | CMS |
| ABBVIE INC. | $17.75 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179836 | CMS |
| ABBVIE INC. | $73.34 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179838 | CMS |
| ABBVIE INC. | $15.15 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179840 | CMS |
| ABBVIE INC. | $4.85 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179842 | CMS |
| ABBVIE INC. | $34.55 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179844 | CMS |
| ABBVIE INC. | $6.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179846 | CMS |
| ABBVIE INC. | $33.17 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179848 | CMS |
| ABBVIE INC. | $26.55 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179850 | CMS |
| ABBVIE INC. | $18.04 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179852 | CMS |
| ABBVIE INC. | $1.16 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179854 | CMS |
| ABBVIE INC. | $10.65 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179856 | CMS |
| ABBVIE INC. | $19.65 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179858 | CMS |
| ABBVIE INC. | $5.97 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179860 | CMS |
| ABBVIE INC. | $8.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179862 | CMS |
| ABBVIE INC. | $8.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179864 | CMS |
| ABBVIE INC. | $10.33 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105179866 | CMS |
| Galderma Laboratories, L.P. | $18.70 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145320315 | CMS |
| Galderma Laboratories, L.P. | $15.75 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145320317 | CMS |
| Galderma Laboratories, L.P. | $19.91 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145320319 | CMS |
| Integra LifeSciences Corporation | $22.80 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140072897 | CMS |
| Kerecis Limited | $35.53 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120114475 | CMS |
| Kerecis Limited | $17.69 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120108137 | CMS |
| Mentor Worldwide LLC | $25.71 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077609826 | CMS |
| MIMEDX Group, Inc. | $25.06 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140266489 | CMS |
| REVANCE THERAPEUTICS, INC. | $89.34 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147926189 | CMS |
| Smith+Nephew, Inc. | $14.51 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149598964 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.